Relay Therapeutics Inc (RLAY)

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.00M% 10.01	-0.001	25.20	0.119	0.226
Operating Expenses	8.87% 100.37	92.19	98.78	106.17	101.40
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	8.87% 100.37	92.19	98.78	106.17	101.40
Operating Income/Loss	1.99% -90.36	-92.20	-73.58	-106.05	-101.18
Income/Loss From Continuing Operations Before Tax	1.00M% 10.01	-0.001	25.20	-98.50	-94.24
Income/Loss From Continuing Operations After Tax	2.52% -81.39	-83.50	-65.73	-98.50	-94.24
Net Income/Loss	2.52% -81.39	-83.50	-65.73	-98.50	-94.24
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	17,740% 130.84	0.7334	122.23	121.68	121.32
Basic Earnings Per Share	7.46% -0.62	-0.67	-0.54	-0.81	-0.78
Diluted Earnings Per Share	7.46% -0.62	-0.67	-0.54	-0.81	-0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-